InsidersTradesSigma
Follow the RAC share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Healthcare & Pharma sector, RAC has published 5 reports. Market capitalisation: €401.9m. The latest transaction was reported on 8 June 2026 (Purchase). Among the most active insiders: Daniel Tillett. The full history is openly available.
5
Insider Decl.
n/a
Thresholds
€18,546
1 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 June 2026
Declarations5 total
0@ A$1.250.067% mcap38.2% of flowShareASXASX:2924-03093792-2A1673848
0@ A$1.250.037% mcap38.2% of flowShareASXASX:2924-03092476-2A1673192
0@ A$1.250.030% mcap31.0% of flowShareASXASX:2924-03090133-2A1672089
0@ A$1.250.030% mcap49.8% of flowShareASXASX:2924-03087778-2A1670871
5 of 5 declarations
About RAC
RAC is a company operating in the healthcare and pharmaceutical sector. It is listed on the XASX market.
